Traduction de «industry during the development » (Néerlandais → Français) :

The “PRE pillar” supports the industry during the development of products, among other means by giving scientific advice and contributing to the compilation of pharmacopoeia monographs.
The “PRE pillar” supports the industry during the development of products, among other means by giving scientific advice and contributing to the compilation of pharmacopoeia monographs.

During the development of the FAMHP, due consideration will be given firstly to the role, functioning and composition of these commissions and consultation platforms and secondly to the representation of the FAMHP.
During the development of the FAMHP, due consideration will be given firstly to the role, functioning and composition of these commissions and consultation platforms and secondly to the representation of the FAMHP.

These were: industrial fabric in Belgium, research and expertise in Belgium, expertise within the FAMHP, development potential, differentiating potential and speed with which expertise can be developed.
These were: industrial fabric in Belgium, research and expertise in Belgium, expertise within the FAMHP, development potential, differentiating potential and speed with which expertise can be developed.

Novartis ranks as having one of the industry’s most competitive pharmaceuticals development pipelines with 147 projects in clinical development, of which 27 involve new molecular entities in late-stage trials or under regulatory review.
Novartis est considéré comme possédant l’un des pipelines de produits pharmaceutiques les plus concurrentiels de l’industrie avec 147 projets en développement clinique, dont 27 impliquent de nouvelles entités moléculaires qui sont en phase ultime d’essais ou en cours d’examen par les autorités réglementaires.

The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.
The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.

Lectures during the following sessions –– Audiologists –– Industrial pharmacists –– Patient safety week –– Radiotherapy round table
Lectures during the following sessions –– Audiologists –– Industrial pharmacists –– Patient safety week –– Radiotherapy round table

In 2010 vonden op het vlak van contacten met de relevante industrie portfolio/ wetenschappelijke vergaderingen plaats en was er op 18 en 19 november 2010 de CTFG Workshop on Early Phase Development in Oncology.
En 2010, les contacts avec l’industrie concernée ont eu lieu lors des réunions portfolio/scientifiques et lors du CTFG Workshop on Early Phase Development in Oncology (18 et 19 novembre 2010).

Novartis has one of the industry’s most competitive pipelines with 143 projects in pharmaceutical clinical development, of which 56 involve new molecular entities.
Novartis possède l’un des pipelines de produits pharmaceutiques les plus compétitifs du secteur avec 143 projets en développement clinique, dont 56 impliquent de nouvelles entités moléculaires.

At Novartis, we put an absolute premium on ethical business conduct and fair dealing. Our credibility provides assurance for those who regulate and invest in our industry, helping us to finance the costs of pharmaceutical development and to run our corporate citizenship programs.
Chez Novartis, nous mettons tout en œuvre pour conduire nos affaires de manière éthique et loyale : la crédibilité et la fiabilité sont les valeurs maîtresses nous permettant de gagner la confiance des autorités réglementaires et des investisseurs, ce qui, en retour, nous aide à financer notre recherche pharmaceutique et à poursuivre notre engagement citoyen.

Compliance with the European directives on electronic submissions Compliance with the European directives requires a number of objectives to be achieved: ●● Arriving at a functional vision of communication standards with EMEA and the Member States in partnership with the industry and in line with European legislation ●● Standard project management, with important steps that are sponsored/supported by the Member States: first developing an IT infrastructure and then starting on a highly secure network followed by so-called “proofs of concept” in each field ●● Success depends above all on the FAHMP’s
Compliance with the European directives on electronic submissions Compliance with the European directives requires a number of objectives to be achieved: ●● Arriving at a functional vision of communication standards with EMEA and the Member States in partnership with the industry and in line with European legislation ●● Standard project management, with important steps that are sponsored/supported by the Member States: first developing an IT infrastructure and then starting on a highly secure network followed by so-called “proofs of concept” in each field ●● Success depends above all on the FAHMP’s